Brentuximab vedotin + AVD (Doxorubicin, Vinblastine, Dacarbazine)
Treatment used for 1 condition
Total Trials
19
Total Participants
8K
Avg Effectiveness
88%
Avg Safety Score
30%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.